NIH PAR · ORIP · R21
PAR-25-273: Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This notice of funding opportunity (NOFO) encourages innovative research to develop, improve, characterize, and preserve animal models as well as animal model related biological materials, technologies, and new approach methodologies (NAMs) for studies relevant to human health and disease. This NOFO also seeks projects aimed at improving the diagnosis and control of diseases that could confound or interfere with animal use in biomedical research. The proposed project must have broad applicability to multiple NIH Institutes or Centers (ICs) to align with the NIH-wide mission of the Office of Research Infrastructure Programs (ORIP). The proposed studies must include animal models and explore…
- NOFO number
- PAR-25-273
- Type
- PAR
- Activity code
- R21
- Primary institute
- ORIP
- Clinical trials
- Not Allowed
- Posted
- Nov 15, 2024
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2028
PAR-25-273 due dates
4 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-273
NIH RePORTER lists 11 projects funded under PAR-25-273 in FY2022–FY2026, with $4.7M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
11
Distinct projects, FY2022–FY2026
New awards
11
Type 1 (new project) award records
NIH funding
$4.7M
Award dollars under PAR-25-273, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 11 | 11 | $4.7M |
Institutions with the most funding
- Seattle Children's Hospital$516K · 1 project
- Jackson Laboratory$487K · 1 project
- Univ of Massachusetts Med Sch Worcester$461K · 1 project
- University of California, San Francisco$451K · 1 project
- Duke University$444K · 1 project
- Ohio State University$433K · 1 project
- Cornell University$432K · 1 project
- University of California Santa Barbara$430K · 1 project
Funding institutes
- OD$4.7M · 11
Activity codes funded
- R2111 records
Most recent new awards
- Enh13 mutant rats for investigation of XX vs. XY differences in phenotypes (opens NIH RePORTER)
Medical College of Wisconsin · 1R21OD042615-01 · OD · Notice Aug 5, 2026
$195KR21
- Transgenesis in a novel mammalian model of adult regeneration (opens NIH RePORTER)
Seattle Children's Hospital · 1R21OD042628-01 · OD · Notice Jul 28, 2026
$516KR21
- Reversible stem cell dormancy in the basal chordate, Botrylloides diegensis (opens NIH RePORTER)
University of California Santa Barbara · 1R21OD042617-01 · OD · Notice Jul 28, 2026
$430KR21
- Addressing the impact of ERVs in genome replicability of mouse resources: CC015 as a proof of principle (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1R21OD042614-01 · OD · Notice Jul 28, 2026
$428KR21
- Repurposing LNP technology to simplify gene editing in nematodes (opens NIH RePORTER)
Univ of Massachusetts Med Sch Worcester · 1R21OD042639-01 · OD · Notice Jul 20, 2026
$461KR21
- A new epitope-tagged estrogen receptor-beta mouse model to facilitate the study of estrogen receptor-beta in disease biology (opens NIH RePORTER)
Ohio State University · 1R21OD037870-01A1 · OD · Notice Jun 26, 2026
$433KR21
What its predecessor PAR-21-167 funded
PAR-25-273 reissues PAR-21-167. Its funding history is the best guide to who wins under this program: 48 projects and $20.8M in FY2022–FY2026.
Projects funded
48
Distinct projects, FY2022–FY2026
New awards
48
Type 1 (new project) award records
NIH funding
$20.8M
Award dollars under PAR-21-167, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 11 | 11 | $2.7M |
| FY2023 | 23 | 12 | $4.7M |
| FY2024 | 26 | 13 | $5.7M |
| FY2025 | 25 | 12 | $5.6M |
| FY2026 | 10 | 0 | $2.0M |
Institutions with the most funding
- Cincinnati Childrens Hosp Med Ctr$1.3M · 3 projects
- Baylor College of Medicine$1.3M · 3 projects
- Jackson Laboratory$1.0M · 2 projects
- University of Texas at Austin$946K · 2 projects
- University of California, San Francisco$895K · 2 projects
- Duke University$853K · 2 projects
- Henry M. Jackson Fdn for the Adv Mil/Med$849K · 2 projects
- University of Nebraska Medical Center$844K · 2 projects
Funding institutes
- OD$20.8M · 95
Activity codes funded
- R2195 records
Most recent new awards
- Development of Mouse Models to Study the Role of Mechanotransduction in Disease Pathogenesis (opens NIH RePORTER)
Rhode Island Hospital · 1R21OD037863-01A1 · OD · Notice Aug 1, 2025
$95KR21
- Development of Transgenic Mouse Model Resources for Red Fluorescence-Based Genetically Encoded Indicator Studies (opens NIH RePORTER)
University of Nebraska Medical Center · 1R21OD037867-01A1 · OD · Notice Jul 31, 2025
$230KR21
- Generation and characterization of PET-reporter pigs for noninvasive imaging and cell therapy research (opens NIH RePORTER)
University of Missouri-Columbia · 1R21OD037856-01 · OD · Notice Jul 14, 2025
$235KR21
- MOLECULAR AND GENETIC CHARACTERIZATION OF EMS-INDUCED LETHAL MUTATIONS IN DROSOPHILA ENRICHED FOR ORTHOLOGS OF HUMAN DISEASE-CAUSING GENES (opens NIH RePORTER)
Baylor College of Medicine · 1R21OD038417-01 · OD · Notice Jul 9, 2025
$241KR21
- Characterizing a novel mouse model linking sphingolipid metabolism to multi-organ fibrosis (opens NIH RePORTER)
University of California, San Francisco · 1R21OD037868-01 · OD · Notice Jul 4, 2025
$246KR21
- A modular system for murine CRISPR genome and epigenome editing (opens NIH RePORTER)
Boston Children's Hospital · 1R21OD037909-01A1 · OD · Notice May 8, 2025
$223KR21
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-273. Contact the program officer at the institute that fits your research before applying.
- ORIP
- none
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets need to reflect the actual needs of the proposed project. No more than 200,000 direct costs may be requested in any single year. The combined budget may not exceed 275,000 direct costs for the two-year project period.
- Project period
- The total project period may not exceed 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-21-167.
Other open NOFOs for R21
- RFA-OD-27-003INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)OD · next due Jun 15, 2027
- PAR-25-068Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)NIDDK · next due Oct 16, 2026
- PAR-25-357NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)NEI · next due Oct 16, 2026
- PA-25-304NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PA-25-306NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)NIH · next due Oct 16, 2026
- PAR-25-346Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.